Chinanews client, Beijing, September 17 (Reporter Zhang Ni) Colorectal cancer is one of the common malignant tumors in China.

A few days ago, the mid-term results of a survey on the diagnosis and treatment of patients with advanced colorectal cancer in China released in Beijing showed that patients have a low level of awareness of all aspects of this disease.

Data show that before getting the disease, 64% of patients did not understand the high-risk factors for colorectal cancer, and 85% lacked knowledge of early screening, which also caused most patients to be in the middle and advanced stages when they were first diagnosed.

Qiao Youlin introduced the results of the mid-term survey at the 4th National Famous Doctors Ceremony (photo provided by the organizer)

　　On the 16th, at the 4th National Famous Doctors Ceremony hosted by the People's Daily Health Client and People's Daily Health Times, the mid-term results of the survey on the diagnosis and treatment of patients with middle and late stage colorectal cancer in China were officially released.

The project was co-sponsored by People's Daily Health Times, Beijing Aipu Cancer Patient Care Foundation, Peking Union Medical College School of Public Health, National Development Research Institute of Peking University, China Health Development Research Center, and Henan Cancer Hospital.

　　The project plans to enroll 4,410 patients with advanced colorectal cancer in 19 research centers in 7 regions across the country. As of July 31, 2020, 50% of the enrollment target has been completed, which is a survey of 2299 patients.

All were one-on-one bedside surveys.

　　One of the principals of the project, Qiao Youlin, a professor at the Chinese Academy of Medical Sciences Tumor Hospital and the Peking Union Medical College School of Medicine and Public Health, pointed out that the survey is comprehensive in terms of medical treatment and treatment status, quality of life, psychological feelings, and patient burden caused by treatment. To understand the status of diagnosis and treatment of patients with advanced colorectal cancer in China.

　　"The survey found that before getting the disease, more than half (64%) of the patients did not understand the high-risk factors of colorectal cancer, 85% of the patients did not understand the knowledge of early colorectal cancer screening; 97% had not undergone colonoscopy screening, of which The main reason why 86.5% of patients did not undergo colonoscopy screening was that they did not know they needed regular colonoscopy screening." As one of the project sponsors, President of the Chinese Anti-Cancer Association Rehabilitation Association, Beijing Aipu Cancer Patient Care Fund Chairman Shi Anli pointed out.

　　The results of the mid-term survey also confirmed this reality. The data showed that 85.8% of the surveyed patients’ first visit was due to suspected symptoms such as blood in the stool, severe diarrhea, or abdominal pain. 7.3% of the patients found abnormalities during the diagnosis and treatment of other diseases, only 6.9% Suspected symptoms were discovered during physical examination.

This has also led to most patients in the middle and late stages when they were first diagnosed.

　　Shen Lin, deputy dean of Peking University Cancer Hospital, pointed out that compared with some European and American countries, the proportion of colorectal patients in China at the time of diagnosis is higher, and there are more patients with metastasis, which brings great challenges to treatment and prognosis.

　　"From the perspective of overall medical expenses, the proportion of patients in the middle and late stages of diagnosis is high, and the country's medical insurance burden will also increase. This requires attention." Li Ling, director of the China Health Development Research Center of the National Development Research Institute of Peking University, said.

　　Li Ling also emphasized that due to the imbalance of regional medical resources, most patients have experienced multiple referrals, and the resulting additional medical expenses will also put pressure on national medical insurance funds.

　　In the opinion of experts at the conference, there are limited access to disease information for colorectal cancer patients, and it is difficult to obtain authoritative and easy-to-understand disease-related knowledge through the Internet.

Therefore, there is a long way to go to educate the public and high-risk groups on disease knowledge.

　　At the meeting, the "Colorectal Cancer Prevention and Treatment Knowledge Popularization Action Plan" was launched, aiming to unite with authoritative experts in the field of colorectal cancer to disseminate to the public the authority of colorectal cancer prevention and treatment knowledge that patients can understand.

(Finish)